Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Medicilon presents new S1PR1 modulators

Jan. 26, 2022

Qilu Regor Therapeutics synthesizes new MAP4K1 inhibitors

Jan. 26, 2022

Shanghai Antengene discloses new ATR kinase inhibitors

Jan. 26, 2022

Hefei Amvite Pharmaceutical patents histamine H1 receptor antagonists

Jan. 26, 2022

Shanghai Newsky Biotechnology identifies PLA2G7 inhibitors

Jan. 25, 2022

Medshine Discovery synthesizes new ER-alpha degradation inducers

Jan. 25, 2022

Wuhan LL Science and Technology Development divulges TRPC5 antagonists

Jan. 25, 2022

Chinese researchers patent new antibacterial compounds

Jan. 25, 2022

Suzhou Vintagence Pharma discloses new GTPase KRAS mutant inhibitors

Jan. 25, 2022

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...